India to Philippines: Glimepiride Export Trade Route
India has recorded 157 verified shipments of Glimepiride exported to Philippines, representing a combined trade value of $3.4M USD. This corridor is served by 27 active Indian exporters, with an average shipment value of $21.7K USD. The leading Indian exporter is AJANTA PHARMA LIMITED, which accounts for 23% of total export value with 12 shipments worth $795.0K USD. On the buying side, AJANTA PHARMA PHILIPPINES INC is the largest importer in Philippines with $795.0K USD in purchases. The top 3 suppliers β AJANTA PHARMA LIMITED, INVENTIA HEALTHCARE LIMITED, MICRO LABS LIMITED β together control 52% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.

Route Intelligence Overview
The India to Philippines Glimepiride corridor is one of India's established pharmaceutical export routes, with 157 shipments documented worth a combined $3.4M USD. The route is dominated by AJANTA PHARMA LIMITED, which alone accounts for roughly 23% of all export value, reflecting the consolidated nature of India's glimepiride manufacturing sector.
Across 27 active suppliers, the average shipment value stands at $21.7K USD β a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 70% of all shipments, consistent with glimepiride's non-urgent bulk-order profile.
Shipment activity peaks during AprilβJune, with an average transit time of 16 days port-to-port. The route has recorded an annual growth rate of 15.4%, placing it at rank #9 among India's top glimepiride export destinations globally.
On the import side, key buyers of Indian glimepiride in Philippines include AJANTA PHARMA PHILIPPINES INC, BROWN AND BURK PHILIPPINES INC, I.E. MEDICA INC. and 36 others. AJANTA PHARMA PHILIPPINES INC is the single largest importer with 12 shipments valued at $795.0K USD.
Route Characteristics
- Average transit16 days
- Peak seasonQ2
- Primary modeSea freight
- Top portAHEMDABAD ICD
Market Position
- Global rank#9
- Annual growth+15.4%
- Demand growth+13.4%
- Regulatory ease72/100
Top 10 Indian Glimepiride Exporters to Philippines
Showing top 10 of 27 Indian suppliers exporting Glimepiride to Philippines, ranked by total trade value (USD)
| Rank | Supplier (Indian Exporter) | Shipments | Total Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | AJANTA PHARMA LIMITED Avg $66.3K per shipment | 12 | $795.0K | 23.3% |
| 2 | INVENTIA HEALTHCARE LIMITED Avg $33.0K per shipment | 16 | $527.2K | 15.5% |
| 3 | MICRO LABS LIMITED Avg $36.7K per shipment | 12 | $440.0K | 12.9% |
| 4 | AZTEC PHARMA PRIVATE LIMITED Avg $20.2K per shipment | 17 | $344.2K | 10.1% |
| 5 | INVENTIA HEALTHCARE LIMITED Avg $52.3K per shipment | 6 | $313.5K | 9.2% |
| 6 | AZTEC PHARMA PRIVATE LIMITED Avg $33.0K per shipment | 8 | $263.7K | 7.7% |
| 7 | SYNMEDIC LABORATORIES Avg $17.3K per shipment | 14 | $241.9K | 7.1% |
| 8 | RAINBOW LIFE SCIENCES PRIVATE LIMITED Avg $12.6K per shipment | 10 | $126.0K | 3.7% |
| 9 | MICRO LABS LIMITED Avg $32.6K per shipment | 2 | $65.1K | 1.9% |
| 10 | RATNATRIS PHARMACEUTICALS PRIVATE LIMITED Avg $2.2K per shipment | 25 | $54.6K | 1.6% |
This table shows the top 10 of 27 Indian companies exporting glimepiride to Philippines, ranked by total trade value. The listed exporters are: AJANTA PHARMA LIMITED, INVENTIA HEALTHCARE LIMITED, MICRO LABS LIMITED, AZTEC PHARMA PRIVATE LIMITED, INVENTIA HEALTHCARE LIMITED , AZTEC PHARMA PRIVATE LIMITED , SYNMEDIC LABORATORIES, RAINBOW LIFE SCIENCES PRIVATE LIMITED, MICRO LABS LIMITED , RATNATRIS PHARMACEUTICALS PRIVATE LIMITED. AJANTA PHARMA LIMITED is the dominant supplier with 12 shipments worth $795.0K USD, giving it a 23% market share. The top 3 suppliers together account for 52% of the total trade value on this route.
Showing top 10 of 27 total Indian exporters on the India to Philippines Glimepiride export route.
Top 10 Glimepiride Importers in Philippines
Showing top 10 of 39 known buyers in Philippines receiving Glimepiride shipments from India, ranked by import value
On the receiving end of this trade route, the leading importers of Indian glimepiride in Philippines include AJANTA PHARMA PHILIPPINES INC, BROWN AND BURK PHILIPPINES INC, I.E. MEDICA INC. , I.E. MEDICA INC., AMBICA INTERNATIONAL CORPORATION, among 39 total buyers. The largest importer is AJANTA PHARMA PHILIPPINES INC, accounting for $795.0K USD across 12 shipments β representing 23% of all glimepiride imports from India on this route.
| Rank | Importer / Buyer | Shipments | Import Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | AJANTA PHARMA PHILIPPINES INC | 12 | $795.0K | 23.3% |
| 2 | BROWN AND BURK PHILIPPINES INC | 12 | $458.1K | 13.4% |
| 3 | I.E. MEDICA INC. | 6 | $313.5K | 9.2% |
| 4 | I.E. MEDICA INC. | 9 | $261.1K | 7.7% |
| 5 | AMBICA INTERNATIONAL CORPORATION | 23 | $259.7K | 7.6% |
| 6 | NA | 10 | $245.7K | 7.2% |
| 7 | I E MEDICA INC | 3 | $211.0K | 6.2% |
| 8 | M/S. MEDETHIX INC. | 5 | $165.1K | 4.8% |
| 9 | AMBICA INTERNATIONAL | 3 | $82.3K | 2.4% |
| 10 | M S MEDETHIX INC | 2 | $65.7K | 1.9% |
Showing top 10 of 39 Glimepiride importers in Philippines on this route.
Top 10 Glimepiride Formulations Imported by Philippines
Showing top 10 of 102 product formulations shipped on the India to Philippines Glimepiride route, ranked by trade value
Philippines imports a wide range of glimepiride formulations from India, spanning tablets, capsules, suspensions, and combination drugs. The top formulation β LUPIMET (GLIMEPIRIDE 2MG AND METFORMIN H β accounts for $208.6K USD across 4 shipments. There are 102 distinct product descriptions in the dataset, reflecting the variety of dosage forms and strengths imported.
| Rank | Product Formulation | Shipments | Trade Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | LUPIMET (GLIMEPIRIDE 2MG AND METFORMIN H | 4 | $208.6K | 6.1% |
| 2 | ASENZA PLUS 30/2 MG TABLETS[12060PACKx3x10=361800TABS]PIOGLITAZONE AND GLIMEPIRIDE TAB]EACH UNCOATED TAB CONT:AS PER INV | 2 | $139.4K | 4.1% |
| 3 | ASENZA PLUS 15/2 MG TABLETS[12600PACKx3x10=378000TABS]PIOGLITAZONE AND GLIMEPIRIDE TAB]EACH UNCOATED TAB CONT:AS PER INV | 2 | $123.6K | 3.6% |
| 4 | LUPIMET GLIMEPIRIDE 2MG AND METFORMIN H | 1 | $104.9K | 3.1% |
| 5 | (AMARAMET)Glimepiride + Metformin Hydroc | 3 | $99.3K | 2.9% |
| 6 | TRIPRIDE 2 (GLIMEPIRIDE 2MG, PIOGLITAZONE HCL 15MG, METFORMIN HCL 500MG TABLETS)(1X10s) - TAX INVOICE NO: 705202586 DT: | 1 | $94.1K | 2.8% |
| 7 | ASENZA PLUS 30/2 MG TABS[12960PACKx3x10=388800 TABS][PIOGLITAZONE AND GLIMEPIRIDE TABS]EACH UNCOATED TAB CONT:AS PER INV | 1 | $74.4K | 2.2% |
| 8 | ASENZA PLUS 30/2 MG TABLETS[12765PACKX3X10=382950 TABS][PIOGLITAZONE AND GLIMEPIRIDE TABS]EACH UNCOATED TABS AS PER INV | 1 | $72.2K | 2.1% |
| 9 | ASENZA PLUS 30/2 MG TABLETS[12655PACKx3x10=379650 TABS][PIOGLITAZONE AND GLIMEPIRIDE TABS]EACH UNCOATED TAB AS PER INV | 1 | $72.2K | 2.1% |
| 10 | ASENZA PLUS 30/2 MG TABS[12595PACKx3x10=377850 TABS][PIOGLITAZONE AND GLIMEPIRIDE TABS] [EACH UNCOATED TABLET AS PER INV | 1 | $70.6K | 2.1% |
Showing top 10 of 102 Glimepiride formulations imported by Philippines on this route.
Shipping & Logistics Analysis
Freight mode split and port-of-origin breakdown
Freight Mode Distribution
Sea freight dominates at 70%, typical for bulk pharmaceutical shipments.
Top Ports of Origin
AHEMDABAD ICD handles the highest volume with 24 shipments. Transit time averages 16 days by sea.
Market Dynamics
India's glimepiride exports to Philippines are driven primarily by a handful of large-scale manufacturers. AJANTA PHARMA LIMITED with 12 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 27 active exporters signals a competitive but concentrated market β buyers in Philippines benefit from supplier diversity while the top tier handles the majority of volume.
The top 3 suppliers β AJANTA PHARMA LIMITED, INVENTIA HEALTHCARE LIMITED, MICRO LABS LIMITED β together account for 52% of total trade value on this route. The average shipment value of $21.7K USD reflects a mix of bulk commercial orders and smaller specialty shipments.
Beyond the primary product category, shipments on this route include closely related formulations such as asenza plus 30/2 mg tablets[12060packx3x10=361800tabs]pioglitazone and glimepiride tab]each uncoated tab cont:as per inv and asenza plus 15/2 mg tablets[12600packx3x10=378000tabs]pioglitazone and glimepiride tab]each uncoated tab cont:as per inv, suggesting that buyers in Philippines tend to consolidate orders across related product lines from the same Indian supplier.
On the buying side, AJANTA PHARMA PHILIPPINES INC is the largest importer with 12 shipments worth $795.0K USD β representing 23% of all glimepiride imports from India on this route. A total of 39 buyers are active on this corridor.
Route Statistics
- Trade Volume
- $3.4M
- Avg. Shipment
- $21.7K
- Suppliers
- 27
- Buyers
- 39
- Transit (Sea)
- ~16 days
- Annual Growth
- +15.4%
Related Analysis
Other Glimepiride Routes
Unlock the Full India to Philippines Glimepiride Dataset
TransData Nexus provides verified shipment-level records, supplier contact details, HS code breakdowns, real-time pricing benchmarks, and regulatory compliance guides for 157 shipments on this route.
Frequently Asked Questions β India to Philippines Glimepiride Trade
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which Indian companies export Glimepiride to Philippines?
The leading Indian exporters of Glimepiride to Philippines are AJANTA PHARMA LIMITED, INVENTIA HEALTHCARE LIMITED, MICRO LABS LIMITED. AJANTA PHARMA LIMITED holds the largest market share at approximately 23% of total trade value on this route.
Q What is the total value of Glimepiride exports from India to Philippines?
India exports Glimepiride to Philippines worth approximately $3.4M USD across 157 recorded shipments. The average value per shipment is $21.7K USD.
Q Which ports does India use to ship Glimepiride to Philippines?
The most active port of origin is AHEMDABAD ICD with 24 shipments. Indian exporters primarily use sea freight for this route, with 70% of shipments going by sea and 19% by air.
Q How long does shipping take from India to Philippines for Glimepiride?
The average transit time for Glimepiride shipments from India to Philippines is approximately 16 days. Sea freight typically takes longer, while air freight can reduce this significantly for urgent orders. Peak shipping activity is observed during AprilβJune.
Q Is the India to Philippines Glimepiride trade route growing?
Yes β this trade corridor has seen an annual growth rate of approximately 15.4% with demand growth tracking at 13.4%. The route is ranked #9 among India's top Glimepiride export destinations globally.
Q How many suppliers are active on the India to Philippines Glimepiride route?
There are currently 27 active Indian suppliers exporting Glimepiride to Philippines. The market is moderately concentrated with AJANTA PHARMA LIMITED accounting for 23% of total shipment value.
Q Who are the main importers of Glimepiride from India in Philippines?
The leading importers of Indian Glimepiride in Philippines include AJANTA PHARMA PHILIPPINES INC, BROWN AND BURK PHILIPPINES INC, I.E. MEDICA INC. , I.E. MEDICA INC., AMBICA INTERNATIONAL CORPORATION. AJANTA PHARMA PHILIPPINES INC is the largest buyer with 12 shipments worth $795.0K USD.
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India β Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce β Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records β the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: India to Philippines export trade corridor identified from Indian Customs (DGFT) records for Glimepiride.
- 2.Supplier/Buyer Matching: 27 Indian exporters and 39 importers in Philippines matched using name normalization.
- 3.Value Aggregation: Total export value aggregated from 157 verified shipping bill records. Values are FOB in USD.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
157 Verified Shipments
27 Indian exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists